• Publications
  • Influence
Increased risk of cancer in patients with gaucher disease
Background. An increased incidence of cancer, especially hematopoietic in origin, has long been suspected but never established in patients with Gaucher disease.
  • 114
  • 7
The role of interleukin‐1 and tumour necrosis factor‐α in human multiple myeloma
This study investigates the capacity of interleukin‐1α (IL‐1α), interleukin‐1β (IL‐1β) and tumour necrosis factor‐α (TNF‐α) to induce interleukin‐6 (IL‐6) production in freshly isolated myeloma cellsExpand
  • 142
  • 5
Serum haptoglobin types and leukemia
SummaryHaptoglobin types were determined on 211 patients with leukemia of the four most common types: acute lymphatic (ALL), chronic lymphatic (CLL), acute myeloid (AML), and chronic myeloid leukemiaExpand
  • 18
  • 4
The role of interleukin-1 and tumour necrosis factor-alpha in human multiple myeloma.
This study investigates the capacity of interleukin-1 alpha (IL-1 alpha), interleukin-1 beta (IL-1 beta) and tumour necrosis factor-alpha (TNF-alpha) to induce interleukin-6 (IL-6) production inExpand
  • 20
  • 3
Hypertonic cryohemolysis: A diagnostic test for hereditary spherocytosis
Red blood cells of subjects with hereditary spherocytosis are specifically susceptible to temperature changes while suspended in hypertonic solutions. Based on this property, a new diagnostic testExpand
  • 16
  • 2
The Physiopathological Significance of Benign Monoclonal Gammopathy: a Study of 64 Cases
Sixty‐four patients with monoclonal protein in serum but initially without evidence of multiple myeloma, macroglobulinaemia, amyloidosis or lymphoma, were studied. Fifty patients (78%) were observedExpand
  • 42
  • 1
Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.
The effect of biosynthetic recombinant insulin-like growth factor I/somatomedin C (IGF-I/Sm-C) and human growth hormone (hGH) on the in vitro growth and maturation of human marrow myeloid progenitorsExpand
  • 177
  • 1
  • PDF
Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin‐like growth factor I
Insulin‐like growth factor I (IGF‐I) is the presumed paracrine or autocrine growth‐promoting mediator of growth hormone in peripheral tissues. In order to evaluate the role of IGF‐I as mediator ofExpand
  • 134
  • 1
Effect of 1,25 dihydroxyvitamin D3 and retinoic acid on normal human pluripotent (CFU-mix), erythroid (BFU-E), and myeloid (CFU-C) progenitor cell growth and differentiation patterns.
The modulatory effect of 1,25 dihydroxyvitamin D3 (vit D) and 13 cis retinoic acid (retinoic acid) on the growth and differentiation of normal human pluripotent stem cell, erythroid, and myeloidExpand
  • 58
  • 1
Treatment of polycythemia vera with hydroxyurea
Thirty‐six patients with polycythemia vera were treated with hydroxyurea for 12 to 67 months. Nineteen patients were previously treated with other drugs. In the vast majority of patients, an averageExpand
  • 74
  • 1